Covington Capital Management’s Fulgent Genetics FLGT Stock Holding History

Covington Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$27K	Buy	700 +400	+133%	+$20.1K	﹤0.01%	665
2022 Q2	$16K	Hold	300	–	–	﹤0.01%	741
2022 Q1	$19K	Hold	300	–	–	﹤0.01%	727
2021 Q4	$30K	Hold	300	–	–	﹤0.01%	612
2021 Q3	$27K	Hold	300	–	–	﹤0.01%	640
2021 Q2	$28K	Hold	300	–	–	﹤0.01%	626
2021 Q1	$29K	Hold	300	–	–	﹤0.01%	545
2020 Q4	$16K	Hold	300	–	–	﹤0.01%	611
2020 Q3	$12K	Hold	300	–	–	﹤0.01%	615
2020 Q2	$5K	Buy	+300	New	+$4.59K	﹤0.01%	692

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covington Capital Management's FLGT Position: Q3 2022 in Review

Covington Capital Management increased its Fulgent Genetics (FLGT) stake by 133% in Q3 2022, buying an estimated $20.1K and bringing the position to 700 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Covington Capital Management first reported a position in FLGT in Q2 2020 and has held it in 10 quarters since. The position peaked at $30K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

Covington Capital Management held 700 shares of Fulgent Genetics worth $27K as of Q3 2022.
Covington Capital Management bought 400 Fulgent Genetics shares in Q3 2022, an estimated $20.1K.
Fulgent Genetics made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #665 holding.
Covington Capital Management first reported a position in Fulgent Genetics in Q2 2020 and has held it in 10 quarters since.
Covington Capital Management's Fulgent Genetics position peaked at $30K in Q4 2021.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.